230 related articles for article (PubMed ID: 36725090)
21. Low dose naltrexone for induction of remission in Crohn's disease.
Parker CE; Nguyen TM; Segal D; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010410. PubMed ID: 29607497
[TBL] [Abstract][Full Text] [Related]
22. Successful Dietary Therapy in Paediatric Crohn's Disease is Associated with Shifts in Bacterial Dysbiosis and Inflammatory Metabotype Towards Healthy Controls.
Verburgt CM; Dunn KA; Ghiboub M; Lewis JD; Wine E; Sigall Boneh R; Gerasimidis K; Shamir R; Penny S; Pinto DM; Cohen A; Bjorndahl P; Svolos V; Bielawski JP; Benninga MA; de Jonge WJ; Van Limbergen JE
J Crohns Colitis; 2023 Jan; 17(1):61-72. PubMed ID: 36106847
[TBL] [Abstract][Full Text] [Related]
23. Crohn's disease exclusion diet in children with Crohn's disease: a case series.
Scarallo L; Banci E; Pierattini V; Lionetti P
Curr Med Res Opin; 2021 Jul; 37(7):1115-1120. PubMed ID: 33951997
[TBL] [Abstract][Full Text] [Related]
24. Is There Evidence of Crohn's Disease Exclusion Diet (CDED) in Remission of Active Disease in Children and Adults? A Systematic Review.
Correia I; Oliveira PA; Antunes ML; Raimundo MDG; Moreira AC
Nutrients; 2024 Mar; 16(7):. PubMed ID: 38613020
[TBL] [Abstract][Full Text] [Related]
25. Role of adjuvant Crohn's disease exclusion diet plus enteral nutrition in asymptomatic pediatric Crohn's disease having biochemical activity: A randomized, pilot study.
Arcucci MS; Menendez L; Orsi M; Gallo J; Guzman L; Busoni V; Lifschitz C
Indian J Gastroenterol; 2024 Feb; 43(1):199-207. PubMed ID: 37610564
[TBL] [Abstract][Full Text] [Related]
26. PRedicting Outcomes For Crohn's dIsease using a moLecular biomarkEr (PROFILE): protocol for a multicentre, randomised, biomarker-stratified trial.
Parkes M; Noor NM; Dowling F; Leung H; Bond S; Whitehead L; Upponi S; Kinnon P; Sandham AP; Lyons PA; McKinney EF; Smith KGC; Lee JC
BMJ Open; 2018 Dec; 8(12):e026767. PubMed ID: 30523133
[TBL] [Abstract][Full Text] [Related]
27. Partial enteral nutrition has no benefit on bone health but improves growth in paediatric patients with quiescent or mild Crohn's disease.
Brückner A; Werkstetter KJ; Frivolt K; Shokry E; Ahmed M; Metwaly A; Marques JG; Uhl O; Krohn K; Hajji M; Otte S; Pozza SB; Bufler P; Liptay S; Haller D; Koletzko B; Koletzko S; Schwerd T
Clin Nutr; 2020 Dec; 39(12):3786-3796. PubMed ID: 32376096
[TBL] [Abstract][Full Text] [Related]
28. Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn's disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study.
Paulides E; Lie MRKL; van der Woude CJ
BMJ Open; 2022 Apr; 12(4):e058358. PubMed ID: 35396307
[TBL] [Abstract][Full Text] [Related]
29. Reverse-engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial.
Lee D; Braly K; Nuding M; Braly I; Hopp C; Twible H; Pope C; Hayden HS; Hoffman L; Zheng H; Wahbeh G; Suskind DL
J Pediatr Gastroenterol Nutr; 2024 May; 78(5):1135-1142. PubMed ID: 38558411
[TBL] [Abstract][Full Text] [Related]
30. Modified Crohn's disease exclusion diet is equally effective as exclusive enteral nutrition: Real-world data.
Niseteo T; Sila S; Trivić I; Mišak Z; Kolaček S; Hojsak I
Nutr Clin Pract; 2022 Apr; 37(2):435-441. PubMed ID: 34339527
[TBL] [Abstract][Full Text] [Related]
31. Probiotics for induction of remission in Crohn's disease.
Limketkai BN; Akobeng AK; Gordon M; Adepoju AA
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD006634. PubMed ID: 32678465
[TBL] [Abstract][Full Text] [Related]
32. Bacterial Taxa and Functions Are Predictive of Sustained Remission Following Exclusive Enteral Nutrition in Pediatric Crohn's Disease.
Jones CMA; Connors J; Dunn KA; Bielawski JP; Comeau AM; Langille MGI; Van Limbergen J
Inflamm Bowel Dis; 2020 Jun; 26(7):1026-1037. PubMed ID: 31961432
[TBL] [Abstract][Full Text] [Related]
33. Partial enteral nutrition induces clinical and endoscopic remission in active pediatric Crohn's disease: results of a prospective cohort study.
Urlep D; Benedik E; Brecelj J; Orel R
Eur J Pediatr; 2020 Mar; 179(3):431-438. PubMed ID: 31781933
[TBL] [Abstract][Full Text] [Related]
34. Early Changes in Microbial Community Structure Are Associated with Sustained Remission After Nutritional Treatment of Pediatric Crohn's Disease.
Dunn KA; Moore-Connors J; MacIntyre B; Stadnyk AW; Thomas NA; Noble A; Mahdi G; Rashid M; Otley AR; Bielawski JP; Van Limbergen J
Inflamm Bowel Dis; 2016 Dec; 22(12):2853-2862. PubMed ID: 27805918
[TBL] [Abstract][Full Text] [Related]
35. Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn's disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial).
Papamichael K; Jairath V; Zou G; Cohen B; Ritter T; Sands B; Siegel C; Valentine J; Smith M; Vande Casteele N; Dubinsky M; Cheifetz A
BMJ Open; 2022 Apr; 12(4):e057656. PubMed ID: 35365535
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of Crohn's Disease Exclusion Diet for Induction of Remission in Crohn's Disease Adult Patients.
Szczubełek M; Pomorska K; Korólczyk-Kowalczyk M; Lewandowski K; Kaniewska M; Rydzewska G
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836367
[TBL] [Abstract][Full Text] [Related]
37. Dietary Therapy With the Crohn's Disease Exclusion Diet is a Successful Strategy for Induction of Remission in Children and Adults Failing Biological Therapy.
Sigall Boneh R; Sarbagili Shabat C; Yanai H; Chermesh I; Ben Avraham S; Boaz M; Levine A
J Crohns Colitis; 2017 Oct; 11(10):1205-1212. PubMed ID: 28525622
[TBL] [Abstract][Full Text] [Related]
38. The Crohn's Disease Exclusion Diet: A Comprehensive Review of Evidence, Implementation Strategies, Practical Guidance, and Future Directions.
Sigall Boneh R; Westoby C; Oseran I; Sarbagili-Shabat C; Albenberg LG; Lionetti P; Manuel Navas-López V; Martín-de-Carpi J; Yanai H; Maharshak N; Van Limbergen J; Wine E
Inflamm Bowel Dis; 2023 Nov; ():. PubMed ID: 37978895
[TBL] [Abstract][Full Text] [Related]
39. Crohn's disease therapeutic dietary intervention (CD-TDI): study protocol for a randomised controlled trial.
Raman M; Ma C; Taylor LM; Dieleman LA; Gkoutos GV; Vallance JK; McCoy KD; Lewis I; Jijon H; McKay DM; Mutch DM; Barkema HW; Gibson D; Rauch M; Ghosh S
BMJ Open Gastroenterol; 2022 Jan; 9(1):. PubMed ID: 35046093
[TBL] [Abstract][Full Text] [Related]
40. Protocol for a randomised, placebo-controlled pilot study for assessing feasibility and efficacy of faecal microbiota transplantation in a paediatric ulcerative colitis population: PediFETCh trial.
Pai N; Popov J
BMJ Open; 2017 Aug; 7(8):e016698. PubMed ID: 28827258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
